0001209191-23-056522.txt : 20231122
0001209191-23-056522.hdr.sgml : 20231122
20231122175129
ACCESSION NUMBER: 0001209191-23-056522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wagner Paul A.
CENTRAL INDEX KEY: 0001612842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 231434625
MAIL ADDRESS:
STREET 1: C/O PFENEX INC.
STREET 2: 10790 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-20
0
0001419041
Forte Biosciences, Inc.
FBRX
0001612842
Wagner Paul A.
C/O FORTE BIOSCIENCES, INC.
3060 PEGASUS PARK DR., BLDG 6
DALLAS
TX
75247
1
1
0
0
See Remarks
0
Common Stock
2023-11-20
4
P
0
5300
0.44
A
1709671
D
Common Stock
2023-11-20
4
P
0
1566
0.43
A
1711237
D
Common Stock
2023-11-20
4
P
0
100
0.4251
A
1711337
D
Common Stock
2023-11-22
4
P
0
400
0.43
A
1711737
D
CEO, Secretary and Chair of the Board
/s/ Paul A. Wagner, Ph.D.
2023-11-22